Obesity is a chronic disease that increases risks for metabolic complications and cardiovascular disease, contributing to an economic burden on health care systems and patients
For people taking GLP-1s, biomarkers can reveal how well your medication is working and whether its having any undesirable effects
The occurrence and magnitude of WR after MBS differs in the literature according to the type of surgery, definition of WR, length of the follow-up period, and follow-up rates
With more than 10 billion worth in the year 2022, the industry is expected to make a growth of approximately 18 billion by the year 2025
Ease of Administration and Compliance: For certain types of research, particularly those involving numerous subjects or extended durations, the simplicity of oral administration can significantly improve adherence
PLoS Pathog (2015) 11(7):e1004903.10.1371/journal.ppat.1004903 178 ReijndersDGoossensGHHermesGDNeisEPvan der BeekCMMostJet alEffects of gut microbiota manipulation by antibiotics on host metabolism in obese humans: a randomized double-blind placebo-controlled trial